TOMO: Summary for TomoTherapy Incorporated - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:48am EST - Canadian Markets open in 3 hours and 42 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

TomoTherapy Incorporated (TOMO)

On Feb 9: 3.89 USD 0.00 (0.00%)

MORE ON TOMO

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

TomoTherapy Incorporated (NasdaqNM:TOMO) Delayed quote data

Last Trade:	3.89 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	3.89
Open:	N/A
Bid:	3.08 x 100
Ask:	N/A
1y Target Est:	4.20

Day's Range:	N/A - N/A
52wk Range:	1.99 - 4.67
Volume:	0
Avg Vol (3m):	169,722
Market Cap:	208.91M
P/E (ttm):	N/A
EPS (ttm):	-0.82
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Free Annual Reports

Add TOMO to Portfolio

Download Data

HEADLINES

•	TomoTherapy Enters Australian Market With Purchase by Royal Brisbane & Women's Hospital
	Marketwire (Tue 9:05am)

•	TOMOTHERAPY INC Financials
	EDGAR Online Financials (Sat, Feb 6)

•	TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 17, 2010
	Marketwire (Fri, Feb 5)

•	Addenbrooke's Hospital Begins Treating Patients on Second TomoTherapy(R) Cancer Treatment System
	Marketwire (Tue, Feb 2)

•	Robbins Umeda LLP Announces Investigation of TomoTherapy Incorporated
	Business Wire (Mon, Feb 1)

•	12 To 24 Month Payback For Hospital Investment In Radiation Oncology Equipment Creates Upside For The Stocks Of These Medical Equipment Suppliers
	Wall Street Transcript (Mon, Jan 25)

•	TOMOTHERAPY INC Files SEC form 10-K/A, Annual Report
	EDGAR Online (Thu, Jan 14)

•	TOMOTHERAPY INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Jan 13)

•	TomoTherapy to Present at Needham Growth Stock Conference
	Marketwire (Mon, Jan 11)

•	Coverage initiated on Tomotherapy by Jefferies & Co
	Briefing.com (Tue, Jan 5)

More Headlines for TOMO...

ANALYST

EPS Est (next year) (Dec-09) :	-0.82
EPS Est (in 2 years) (Dec-10) :	-0.61
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

TomoTherapy, Incorporated and its subsidiaries develop, manufacture, market, and sell the Hi Art system, a radiation therapy system for the treatment of various types of cancer.

Full Company Profile

Add to Portfolio

Email to a Friend

•